Catalyst Biosciences, Inc.
(NASDAQ : CBIO)

( )
CBIO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. 0.94%245.371.5%$940.74m
MRNAModerna, Inc. 0.71%144.270.0%$849.73m
REGNRegeneron Pharmaceuticals, Inc. 0.84%612.492.6%$526.18m
VRTXVertex Pharmaceuticals, Inc. 3.19%292.551.9%$516.29m
GILDGilead Sciences, Inc. 0.80%63.081.0%$513.27m
NVAXNovavax, Inc. -0.27%51.6775.7%$422.21m
ILMNIllumina, Inc. 0.20%193.933.3%$361.41m
BIIBBiogen, Inc. 0.26%211.931.8%$242.32m
SNSSSunesis Pharmaceuticals, Inc. 9.63%2.960.7%$206.91m
CRSPCRISPR Therapeutics AG 2.78%66.960.6%$173.29m
BNTXBioNTech SE 1.32%134.040.0%$153.17m
BMRNBioMarin Pharmaceutical, Inc. 2.72%86.854.2%$121.28m
EXASEXACT Sciences Corp. 6.89%45.1517.7%$107.32m
IOVAIovance Biotherapeutics, Inc. 0.19%10.350.0%$103.94m
TECHBio-Techne Corp. 2.16%352.764.5%$95.22m

Company Profile

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA.